
Engineering and Application of Pluripotent Stem Cells
Springer (Publisher)
Published on 3. January 2019
Book
Paperback/Softback
VII, 228 pages
978-3-030-08817-0 (ISBN)
Description
This book reviews the latest biotechnological advances with pluripotent stem cells, exploring their application in tissue engineering and medicinal chemistry. Chapters from expert contributors cover topics such as the production of transgene-free induced pluripotent stem cells (iPSCs), expansion, controlled differentiation and programming of pluripotent stem cells, and their genetic instability. Particular attention is given to the application of the pluripotent stem cells for vascularision of engineered tissue and for drug screening.
This book will appeal to researchers working in regenerative medicine and drug discovery, and to bioengineers and professionals interested in stem cell research.
More details
Series
Edition
Softcover Reprint of the Original 1st 2018 ed.
Language
English
Place of publication
Cham
Switzerland
Publishing group
Springer International Publishing
Target group
Professional and scholarly
Illustrations
VII, 228 p.
Dimensions
Height: 235 mm
Width: 155 mm
Thickness: 13 mm
Weight
365 gr
ISBN-13
978-3-030-08817-0 (9783030088170)
DOI
10.1007/978-3-319-73591-7
Schweitzer Classification
Other editions
Additional editions

Ulrich Martin | Robert Zweigerdt | Ina Gruh
Engineering and Application of Pluripotent Stem Cells
Book
03/2018
Springer
€320.99
Shipment within 10-15 days
Content
Nonintegrating Human Somatic Cell Reprogramming Methods.- Scalable Expansion of Pluripotent Stem Cells.- Scalable Cardiac Differentiation of Pluripotent Stem Cells Using Specific Growth Factors and Small Molecules.- Specific Cell (Re-)Programming: Approaches and Perspectives.- Bioengineered Cardiac Tissue Based 4 on Human Stem Cells for Clinical Application.- Human Pluripotent Stem Cells to Engineer Blood Vessels.- Targeted Gene Editing in Human Pluripotent Stem Cells Using Site-Specific Nucleases.- Acquired Genetic and Epigenetic Variation in Human Pluripotent Stem Cells.- Requirements for Using iPSC-Based Cell Models for Assay Development in Drug Discovery.